Real People. Real Lives. Really Faced Esophageal Cancer.
Esophageal Cancer is
One American Dies of Esophageal Cancer
Every 36 Minutes
Esophageal Cancer is one of the fastest increasing
cancer diagnoses in the western world
Increasing 600% in the past 35 years
Esophageal Cancer is among the deadliest of diseases
Fewer than One in Five Patients will Survive Five Years
Esophageal Cancer is among the cancers that
Receive the Least Amount of Federal Research Funding
- stressing the crucial link between Reflux Disease and Esophageal Cancer
- fostering prevention and early detection among those at risk
- supporting medical research into prevention, early detection, treatment and
- connecting patients and caregivers with resources for information, encouragement and compassionate support
Latest News and Events
ECAN petitioned the U.S. Food and Drug Administration (FDA) for new labels on over-the-counter (OTC) heartburn medications warning of the risk of Esophageal Cancer. The Citizen Petition requests that the FDA order new labels on all OTC acid reflux medications.
One of ECAN’s first advocacy successes has borne fruit! The genome mapping study of Esophageal Cancer has been published and its findings will certainly spur progress in the fight against this deadly cancer.
The Budget proposal sent to Congress calls for a 20% reduction in spending by the National Institutes of Health. Advocates say it will be “catastrophic” for the future of cancer research in the U.S. You can let Congress know you oppose those cuts using our advocacy tools.